Prostate Cancer Treatment Resistant: New Insights into BCL-2 Survival Mechanism
Researchers have identified the PIM1 kinase pathway as a critical survival mechanism in prostate cancer, allowing tumors to evade standard therapies like androgen deprivation and chemotherapy. Published this week in ... Read More